Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal

Chikara Takahashi, Robert S. Mittler and Anthony T. Vella
J Immunol May 1, 1999, 162 (9) 5037-5040;
Chikara Takahashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert S. Mittler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony T. Vella
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Kinetics of 4-1BB expression on in vivo activated T cells. B10.A mice were injected with 0.30 μg of SEA. At various times after SEA injection, LN T cells were purified. These cells were stained for CD4 Vβ3 4-1BB (left panel) and CD8 Vβ3 4-1BB (right panel) and analyzed by flow cytometry (solid lines). 4-1BB expression on T cells from an uninjected normal mouse (dotted lines) is shown. This is one experiment similar to three others.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Time course of SEA-stimulated CD4 T cell deletion with and without 4-1BB activation. B10.A mice were coinjected with 0.10 mg of anti-4-1BB mAb 3H3 (○) or 0.1 mg rat IgG (□) and 0.30 μg of SEA. Splenic T cells were purified on days 2, 5, 7, 12, and 21 after SEA injection. T cells were stained for CD4 Vβ3 and analyzed by flow cytometry. Each point represents the mean percentages (A) and numbers (B) ± SEM from six mice over three separate experiments combined.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Time course of SEA-stimulated CD8 T cell deletion with and without 4-1BB activation. These data are from the experiments described in Fig. 2, except the cells were stained (A) and enumerated (B) for CD8 Vβ3. Data from LN were similar (not shown).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Survival of SEA-stimulated and unstimulated CD8 T cells in vitro with and without 4-1BB activation. Three female B10.A mice were set up as follows: one was uninjected (□); one was injected with 0.20 mg of anti-4-1BB mAb 3H3 and 0.30 μg SEA (○); and one was injected with 0.20 mg of rat IgG and 0.30 μg SEA (⋄). LN T cells were purified 2 days after injections and cultured at 2 × 106 cells per well in a 96-well plate. T cells were stained and enumerated for CD8 Vβ14 (data not shown) and CD8 Vβ3 expression at 0, 8, 12, and 16 h in culture. Each data point represents the mean numbers ± SEM from triplicate samples for each injection regimen. These data are comparable to three other experiments.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 162 (9)
The Journal of Immunology
Vol. 162, Issue 9
1 May 1999
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
Chikara Takahashi, Robert S. Mittler, Anthony T. Vella
The Journal of Immunology May 1, 1999, 162 (9) 5037-5040;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
Chikara Takahashi, Robert S. Mittler, Anthony T. Vella
The Journal of Immunology May 1, 1999, 162 (9) 5037-5040;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells
  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
  • Cutting Edge: NOX2 NADPH Oxidase Controls Infection by an Intracellular Bacterial Pathogen through Limiting the Type 1 IFN Response
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606